izpis_h1_title_alt

Vrednotenje termičnih lastnosti vodnih raztopin izbranih pomožnih snovi za liofilizacijo
ID Gomboc, Eva (Avtor), ID Planinšek, Odon (Mentor) Več o mentorju... Povezava se odpre v novem oknu, ID Ahlin Grabnar, Pegi (Komentor)

.pdfPDF - Predstavitvena datoteka, prenos (3,78 MB)
MD5: F1332A0FB516FC316CA15794971A1BCE

Izvleček
Liofilizacijo oz. sušenje z zamrzovanjem uporabljamo za povečanje stabilnosti proteinskih zdravilnih učinkovin. Na ta način upočasnimo kemijske in fizikalne procese, omogočimo lažje rokovanje z zdravilom ter olajšamo transport. Ker je liofilizacija stroškovno in časovno potraten proces, lahko z načrtovanjem ustrezne formulacije cikel skrajšamo in tako povečamo ekonomičnost procesa. Zaradi obremenitev proteinske zdravilne učinkovine z nizkimi temperaturami in nizkim tlakom med procesom mora formulacija poleg zdravilne učinkovine vsebovati pomožne snovi, ki jo bodo zaščitile pred temi vplivi in tudi kasneje med procesom transporta in shranjevanjem. V okviru magistrske naloge smo izdelali formulacije s polnilom v kristalinični obliki (glicin) in različnimi stabilizatorji. Uporabili smo saharozo, trehalozo dihidrat, ?-ciklodekstrin, sorbitol, PEG 4.000, PVP 10.000 in PVP 40.000. Proučevali smo, ali lahko saharozo nadomestimo z drugim stabilizatorjem. Vodne raztopine zmesi glicina in stabilizatorja v razmerjih 6 : 1, 5 : 2 in 1 : 6 (v koncentracijah 0,1 g/mL oz. 0,2 g/mL) smo analizirali z diferenčno dinamično kalorimetrijo, s katero smo izmerili temperaturo steklastega prehoda maksimalno koncentrirane zamrznjene raztopine (Tg'). Višje Tg' omogočajo krajši čas primarnega sušenja in tako prispevajo h krajšemu liofilizacijskemu ciklu. Formulacije smo izpostavili agresivnemu liofilizacijskemu ciklu (temperatura produkta med primarnim sušenjem je presegla Tg') in ovrednotili proces s pomočjo procesnega grafa in vizualnega pregleda liofilizatov. Tudi liofilizate smo analizirali z diferenčno dinamično kalorimetrijo in jim izmerili temperaturo steklastega prehoda (Tg). Na koncu smo izmerili Tg liofilizatov z modelno proteinsko učinkovino ter Tg' po rekonstituciji liofilizatov in s tem preverili vpliv proteina na termične lastnosti formulacij. Formulacije s proteinom so bile pripravljene s saharozo v koncentracijah 20 in 30 mg/mL ter z glicinom in saharozo v razmerjih 1 : 2 (v koncentraciji 20 mg/mL) in 2 : 1 (v koncentraciji 30 mg/mL) . Rezultati so pokazali, da imajo vse analizirane formulacije zmesi, pri katerih smo zaznali Tg', le-to višjo od zmesi glicina in saharoze. Prav tako vodne raztopine vseh zmesi razen glicina in sorbitola v razmerju 1 : 6 po liofilizaciji tvorijo pogačo sprejemljivega videza. Po merjenju Tg liofilizatov smo ugotovili, da je najprimernejša pomožna snov za nadomestitev saharoze v formulacijah za liofilizacijo PVP 10.000, saj ima višje Tg' kot saharoza in izkazuje visoke Tg liofilizatov. Glede na visoke izmerjene Tg' bi lahko v formulacijah s proteinom uporabili tudi ?-ciklodekstrin, kljub temu da Tg pri analizi liofilizatov nismo zaznali. Prav tako Tg nismo zaznali pri zmeseh glicina s PEG 4.000, a liofilizati sprejemljivega videza nakazujejo na stabilnost formulacij. Meritve formulacij z dodano proteinsko učinkovino so pokazale zvišanje Tg in s tem napoved boljše stabilnosti v času shranjevanja, a hkrati znižan Tg', kar lahko pomeni daljši liofilizacijski cikel, saj je potrebna daljša faza primarnega sušenja, to pa lahko vpliva na stabilnost formulacij med procesom liofilizacije.

Jezik:Slovenski jezik
Ključne besede:liofilizacija, pomožne snovi, biološka zdravila, DSC, temperatura steklastega prehoda maksimalno koncentrirane zamrznjene raztopine (Tg')
Vrsta gradiva:Magistrsko delo/naloga
Organizacija:FFA - Fakulteta za farmacijo
Leto izida:2019
PID:20.500.12556/RUL-108409 Povezava se odpre v novem oknu
Datum objave v RUL:02.07.2019
Število ogledov:1347
Število prenosov:280
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Sekundarni jezik

Jezik:Angleški jezik
Naslov:Thermal characteristics evaluation of water solutions containing selected excipients for lyophilization
Izvleček:
Lyophilization or freeze-drying is used to increase the stability of protein active ingredients. In this way, we slow down the chemical and physical processes, facilitate the handling of the drug and facilitate transport. Since lyophilization is a cost-effective and time-consuming process, by designing the appropriate formulation, the cycle can be shortened to increase the cost-effectiveness of the process. Due to the burden of protein active ingredient on the low-temperature and low-pressure during the process the formulation must also contain, in addition to the active ingredient, excipients that will protect it from these effects and also later during the transport and storage. Within the master's thesis, formulations with crystalline bulking agent glycine and various stabilizers were made. We used: sucrose, trehalose dihydrate, ?-cyclodextrin, sorbitol, PEG 4.000, PVP 10.000 and PVP 40.000. We studied whether the sucrose can be replaced by another stabilizer. Aqueous solutions of a mixture of glycine and stabilizer in 6 : 1, 5 : 2 and 1 : 6 ratios (at a concentration of 0,1 mg/mL or 0,2 mg/mL) were analyzed by differential dynamic calorimetry to measure the glass transition temperature of the maximum concentrated frozen solution (Tg'). Higher Tg' allows a shorter primary drying time and thus contribute to a shorter lyophilization cycle. The formulations were exposed to the aggressive lyophilization cycle (the product temperature during primary drying exceeded Tg') and the process was evaluated through the process graph and a visual examination of lyophilizates. The lyophilizates were also analyzed by differential dynamic calorimetry and the glass transition temperature (Tg) was measured. Finally, we measured the Tg of the lyophilizates containing model protein ingredient and Tg' after the reconstitution of lyophilizates, thereby checking the effect of the protein on the thermal properties of the formulations. Protein formulations were prepared with sucrose at concentrations of 20 and 30 mg/mL and with glycine and sucrose in ratios of 1 : 2 (at a concentration of 20 mg/mL) and 2 : 1 (at a concentration of 30 mg/mL). The results showed that all of the analyzed formulations of the mixtures in which Tg' were detected they were higher than the mixture of glycine with sucrose. Similarly, aqueous solutions of all mixtures other than glycine and sorbitol in a ratio of 1 : 6 after lyophilization form an acceptable cake appearance. After measurement of Tg of lyophilizates, PVP 10.000 was found to be the most optimal excipient for the replacement of sucrose in lyophilization formulations, because it has higher Tg' than sucrose and high Tg of lyophilizates. Depending on the high measured Tg', ?-cyclodextrin could also be used in protein formulations, although Tg was not detected in the analysis of lyophilizates. We also did not detect Tg in mixtures of glycine and PEG 4,000, but lyophilizates of acceptable appearance suggest a stability of these formulations. Measurements of the added protein-formulated formulations showed an increase in Tg and thus a prediction of better stability during storage, but at the same time decreased Tg', which could mean a longer lyophilization cycle, since a longer phase of primary drying is required, which may affect the stability of the formulations during the lyophilization process.

Ključne besede:lyophlilization, excipients, biologic drugs, DSC, glass transition temperature of maximally freeze concentrated solution (Tg')

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj